27.08.2025 • News

BASF and Yara End Joint Project for Low-Carbon Ammonia at US Gulf Coast

BASF and Yara International have jointly decided to discontinue their project to develop a low-carbon ammonia production facility with carbon capture and storage in the US Gulf Coast region. This decision reflects the companies’ commitment to focus on initiatives with the highest potential to achieve their respective value creation goals.

Yara BASF Ammonia Plant Freeport
Yara BASF Ammonia Plant Freeport
© Yara

Both companies originally announced in 2023 a feasibility study to build a large-scale US plant to produce blue ammonia with significant CO₂ capture, aiming to meet global low-carbon ammonia demand and advance their decarbonization goals. 

Yara will continue its ammonia strategy as previously communicated, evaluating and maturing equity investment opportunities in U.S. ammonia to determine the optimal project portfolio.

BASF and Yara are long-standing collaboration partners and continue to jointly operate a world-scale ammonia plant at BASF’s site in Freeport, Texas. Additionally, BASF produces ammonia in Ludwigshafen, Germany, and Antwerp, Belgium. Yara operates the world’s largest ammonia system with production facilities in Europe, the Americas and Asia.

Company

Logo:

BASF SE

Carl-Bosch-Straße 38
67056 Ludwigshafen
Germany

Company contact







From Catalogue to Collaboration

Enamine's Expert Insights Collection Is Free to Download
Enamine’s 35 Years of Advancing Drug Discovery

Enamine's Expert Insights Collection Is Free to Download

From catalogue to collaboration — explore 35 years of drug discovery breakthroughs, novel building blocks, and the science shaping tomorrow's medicines. Download your complimentary copy now.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read